查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1827710

2025年全球心臟瓣膜市場報告

Cardiac Valve Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，心臟瓣膜市場快速擴張，從2024年的108.9億美元成長至2025年的124.1億美元，複合年成長率達13.9%。過去的成長可歸因於人口老化及其導致的心臟瓣膜疾病發病率上升、肥胖和高血壓等危險因素的患病率上升、心臟瓣膜疾病診斷和影像學技術的進步、心臟健康和心臟瓣膜疾病宣傳活動和教育的開展，以及微創和經導管心臟瓣膜疾病治療技術的進步。

預計未來幾年心臟瓣膜市場將快速成長，到 2029 年將達到 212.2 億美元，複合年成長率為 14.4%。預測期內的成長動力來自以下因素：對生物工程和組織工程心臟瓣膜的需求不斷成長、全球人口老化、對心臟瓣膜疾病治療的需求、心臟瓣膜疾病患者的遠距遠端醫療和遠端患者監護、心臟瓣膜疾病手術技術的改進和機器人輔助治療，以及 3D 列印在個人化心臟瓣膜製造中的應用。預測期內的主要趨勢包括瓣膜置換和修復技術的進步、人工智慧 (AI) 在瓣膜疾病檢測和治療計劃中的應用、3D 列印在個人化心臟瓣膜製造中的應用、瓣膜置換和修復技術的進步、手術技術的改進和機器人輔助瓣膜手術。

心臟瓣膜是一種人工裝置，用於調節心臟內的血流，並確保血液從心臟單向流向身體其他部位。這些植入式裝置在替換因各種疾病而停止功能的受損瓣膜方面發揮著重要作用。心臟瓣膜的主要作用是維持血液在心臟內以及連接心臟的主要血管中的正常流動。

心臟瓣膜的主要類型包括組織瓣膜、經導管瓣膜、機械瓣膜等。組織瓣膜用於開胸手術和微創手術，以防止血管內血栓形成。這些瓣膜由捐贈者的耐用且柔韌的動物組織製成，用於心臟瓣膜修復和置換術。心臟瓣膜的修復或置換適用於心臟的不同部位，包括主動脈瓣和二尖瓣。心臟瓣膜的最終使用者包括醫院、診所、專科中心、心臟研究機構和其他醫療機構。

2025年春季，美國關稅飆升及其引發的貿易摩擦對醫療設備產業產生了重大影響，尤其對用於診斷影像設備的進口零件、手術用不銹鋼和一次性塑膠製品產生了重大影響。由於醫院和診所抵制漲價，製造商面臨利潤壓力。監管挑戰使情況更加複雜，因為由於關稅而更換供應商通常需要重新認證醫療設備，導致市場准入延遲。為此，企業正在透過雙重採購關鍵零件、增加標準化產品的國內生產以及加快尋找更具成本效益的材料來降低風險。

本研究報告是商業研究公司 (The Business Research Company) 新報告系列的一部分，該系列提供心臟瓣膜市場統計數據，例如全球市場規模、區域佔有率、心臟瓣膜市場佔有率競爭對手、詳細的心臟瓣膜細分市場、市場趨勢和機遇，以及您在心臟瓣膜行業取得成功所需的數據。本心臟瓣膜市場研究報告對該行業的現狀和未來趨勢進行了詳細分析，為您提供所需的一切觀點。

未來五年預測成長率為14.4%，較我們先前對該市場的預測略有下降0.1%。下降主要源自於美國與其他國家之間關稅的影響。這種影響可能會直接波及美國，導致來自加拿大和奧地利等主要地區的心包組織補片和支架瓣膜組件的供應鏈中斷，從而可能導致瓣膜置換術等待時間延長和設備價格上漲。由於互惠關稅以及貿易緊張局勢和限制措施加劇對全球經濟和貿易的負面影響，這種影響也將更加廣泛地蔓延。

心血管疾病的日益普及推動了心臟瓣膜市場的成長。吸菸、肥胖、缺乏運動等心血管壓力因素導致心血管疾病的發生率逐漸上升。冠狀動脈疾病是常見的原因，其特徵是動脈中脂肪斑塊的堆積。心臟相關疾病的激增推動了對用於治療心臟瓣膜問題的心臟瓣膜的需求。根據世界衛生組織 (WHO) 的數據，截至 2023 年 9 月，心血管疾病佔全球非傳染性疾病 (NCD) 或慢性疾病相關死亡人數的很大一部分，約為 74%。

預計心臟瓣膜市場的擴張將受到醫療支出成長的推動。醫療保健支出涵蓋與醫療保健產品和服務相關的成本，是支持心臟瓣膜研發和普及的關鍵因素。 2022年11月，加拿大衛生資訊研究所報告稱，2022年醫療保健支出將成長0.8%，達到3,310億美元，而2021年的成長率為7.6%。醫療保健支出成長的趨勢是心臟瓣膜市場成長的促進因素。

心臟瓣膜市場的一個顯著趨勢是技術進步的融合。產業主要參與企業正專注於新生血管心臟瓣膜植入物、環狀成形術術環和機器人手術等創新技術，以提升其市場佔有率。這些技術進步有助於為心臟病提供微創治療方案，並為患者提供保護，使其免受心肌梗塞和心臟麻痹等危及生命的疾病的侵害。 2022年9月，美國領先的醫療科技公司Edwards推出了Sapien 3 Ultra Resilia經導管心臟瓣膜，該瓣膜採用抗鈣化技術。此技術平台旨在不可逆地阻斷生物瓣膜中的鈣結合位點。

心臟瓣膜市場的主要企業正在積極開發創新產品，例如推出下一代經導管主動脈瓣植入 (TAVI) 系統，這些系統正在推動市場收益。美國知名醫療設備公司雅培於 2022 年 12 月推出了 Navitor TAVI 系統。這種自膨脹瓣膜旨在治療有症狀的嚴重主動脈瓣狹窄且被認為開胸手術風險高或極高的患者。 Navitor TAVI 系統融合了智慧設計功能，包括智慧 PVL 密封 NaviSeal 袖帶、穩定精確的放置、卓越的個位數梯度和不受影響的小血管通路，可適應從常規到具有挑戰性的各種解剖結構。

2022年1月，專注於結構性心臟病治療的中國公司啟明醫療完成了對以色列醫療設備公司CardioValve的收購，後者專注於經股動脈二尖瓣置換系統的研發。這項策略性舉措將使啟明醫療得以推進其在歐洲和美國的臨床研究，同時加速其在中國的臨床開發和商業化進程。此次收購使啟明醫療成為中國治療二尖瓣和瓣膜閉鎖不全最全面的平台。

心臟瓣膜市場的主要企業包括雅培實驗室、Colibri Heart Valve LLC、TTK HealthCare Limited、Artivion Inc.、Edwards Lifesciences Corporation、波士頓科學公司、Jenavalve Technology Inc.、CryoLife Inc.、樂普醫療科技有限公司、Braille Biomedical、Sorin Group、Micro Interventional Devices Inc.、美敦科技公司、愛德華Ltd.、Auto Tissue Berlin GmbH、On-X Life Technologies Inc.、Thubrikar Aortic Valve Inc. 和 LifeNet Health Inc.。

2024年，北美是心臟瓣膜市場最大的地區。預計亞太地區將成為預測期內成長最快的地區。心臟瓣膜市場報告涵蓋亞太地區、西歐、中歐和東歐、北美、南美以及中東和非洲。

心臟瓣膜市場報告涉及的國家有澳洲、巴西、中國、法國、德國、印度、印尼、日本、俄羅斯、韓國、英國和美國。

心臟瓣膜市場包括三尖瓣和肺動脈瓣的銷售。該市場的價值是“出廠價”，即商品製造商或生產商銷售給其他營業單位（包括下游製造商、批發商、經銷商和零售商）或直接銷售給最終客戶的商品價值。該市場中的商品價值還包括商品製造商銷售的任何相關服務。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通膨、地緣政治、貿易戰和關稅，以及新冠疫情和復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球心臟瓣膜：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
  • 最終用途產業分析
  • 全球心臟瓣膜市場：成長率分析
  • 全球心臟瓣膜市場表現：規模與成長，2019-2024
  • 全球心臟瓣膜市場預測：規模與成長，2024-2029年，2034年
  • 全球心臟瓣膜：總目標市場（TAM）

第6章 市場細分

  • 全球心臟瓣膜市場類型、績效及預測（2019-2024、2024-2029、2034）
  • 組織心臟瓣膜
  • 經導管心臟瓣膜
  • 人工心臟瓣膜
  • 其他
  • 全球心臟瓣膜市場分佈、表現及預測（2019-2024、2024-2029、2034）
  • 主動脈瓣
  • 二尖瓣
  • 其他
  • 全球心臟瓣膜市場（按治療、表現和預測），2019-2024 年、2024-2029 年、2034 年
  • 心臟瓣膜修復
  • 心臟瓣膜置換術
  • 全球心臟瓣膜市場（依最終使用者、績效及預測），2019-2024 年、2024-2029 年、2034 年
  • 醫院和診所
  • 專業中心
  • 心臟研究所
  • 其他
  • 全球心臟瓣膜市場：組織心臟瓣膜細分市場，按類型、性能和預測，2019-2024 年、2024-2029 年、2034 年
  • 生物瓣膜（例如豬、牛）
  • 同種異體瓣膜
  • 全球心臟瓣膜市場：經導管心臟瓣膜細分市場，按類型、性能和預測，2019-2024 年、2024-2029 年、2034 年
  • 經導管主動脈瓣置入術（TAVI）瓣膜
  • 經導管二尖瓣瓣膜修復
  • 全球心臟瓣膜市場：人工心臟瓣膜細分市場，按類型、性能和預測，2019-2024 年、2024-2029 年、2034 年
  • 斜盤閥
  • 雙葉瓣
  • 籠式球閥
  • 全球心臟瓣膜市場：其他細分市場、按類型、實際結果和預測，2019-2024 年、2024-2029 年、2034 年
  • 導管
  • 有支架瓣膜和無支架瓣膜

第7章 區域和國家分析

  • 全球心臟瓣膜市場：2019-2024 年、2024-2029 年和 2034 年區域表現和預測
  • 全球心臟瓣膜市場：國家、績效及預測（2019-2024、2024-2029、2034）

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

  • 心臟瓣膜市場：競爭格局
  • 心臟瓣膜市場：公司簡介
    • Abbott Laboratories
    • Colibri Heart Valve LLC
    • TTK HealthCare Limited
    • Artivion Inc.
    • Edwards Lifesciences Corporation

第31章：其他領先和創新企業

  • Boston Scientific Corporation
  • Jenavalve Technology Inc.
  • CryoLife Inc.
  • Lepu Medical Technology Co. Ltd.
  • Braile Biomedical
  • Sorin Group
  • Micro Interventional Devices Inc.
  • Medtronic Inc.
  • Lepu Medical Technology
  • Edward Lifesciences Corporation
  • Xeltis AG
  • Meril Life Sciences Pvt. Ltd.
  • Auto Tissue Berlin GmbH
  • On-X Life Technologies Inc.
  • Thubrikar Aortic Valve Inc.

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第35章：市場潛力大的國家與策略

  • 2029 年心臟瓣膜市場：提供新機會的國家
  • 2029 年心臟瓣膜市場：細分市場帶來新機會
  • 2029年心臟瓣膜市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第36章 附錄

簡介目錄
Product Code: r21193u

Cardiac valves are artificial devices designed to regulate the flow of blood within the heart, ensuring unidirectional blood movement from the heart to other parts of the body. These implantable devices play a crucial role in replacing damaged valves that may have ceased functioning due to various diseases. The primary objective of cardiac valves is to maintain the proper flow of blood through the heart and into the major blood vessels connected to it.

The primary types of cardiac valves include tissue valves, transcatheter valves, mechanical valves, and other variations. Tissue heart valves, utilized in open-heart or minimally invasive surgeries, aim to prevent blood clot formation inside the vessels. These valves are crafted from durable and flexible animal tissue obtained from donors and are employed in cardiac valve repair and replacement procedures. Various positions in the heart, such as the aortic valve and mitral valve, necessitate the repair or replacement of cardiac valves. End-users of cardiac valves include hospitals, clinics, specialty centers, cardiac research institutes, and other healthcare facilities.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The cardiac valve market research report is one of a series of new reports from The Business Research Company that provides cardiac valve market statistics, including cardiac valve industry global market size, regional shares, competitors with a cardiac valve market share, detailed cardiac valve market segments, market trends and opportunities, and any further data you may need to thrive in the cardiac valve industry. This cardiac valve market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The cardiac valve market size has grown rapidly in recent years. It will grow from $10.89 billion in 2024 to $12.41 billion in 2025 at a compound annual growth rate (CAGR) of 13.9%. The growth in the historic period can be attributed to aging population and the associated increase in valvular heart disease, growth in the prevalence of risk factors like obesity and hypertension, improved diagnostic and imaging technologies for valve diseases, awareness campaigns and education on heart health and valve disease, and development of minimally invasive and transcatheter valve procedures.

The cardiac valve market size is expected to see rapid growth in the next few years. It will grow to $21.22 billion in 2029 at a compound annual growth rate (CAGR) of 14.4%. The growth in the forecast period can be attributed to increasing demand for bioengineered and tissue-engineered heart valves, aging global population andThe need for valve disease treatment, telemedicine and remote patient monitoring for valve patients, enhanced surgical techniques and robotics-assisted valve procedures, and adoption of 3D printing for personalized heart valve manufacturing. Major trends in the forecast period include advancements in valve replacement and repair techniques, integration of artificial intelligence (ai) for valve disease detection and treatment planning, adoption of 3D printing for personalized heart valve manufacturing, advancements in valve replacement and repair techniques, and enhanced surgical techniques and robotics-assisted valve procedures.

The forecast of 14.4% growth over the next five years indicates a slight reduction of 0.1% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through supply chain disruptions for pericardial tissue patches and stent-mounted valve assemblies, sourced from key regions such as Canada and Austria, which could lead to longer wait times for valve replacement procedures and higher device prices.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The increasing prevalence of cardiovascular diseases is poised to drive the growth of the cardiac valve market. Factors such as smoking, obesity, lack of physical activity, and other cardiovascular stressors contribute to a gradual rise in cardiovascular diseases. Coronary artery disease, characterized by the build-up of fatty plaques in arteries, is a common cause. This surge in heart-related ailments has heightened the demand for cardiac valves to address heart valve issues. As of September 2023, data from the World Health Organization indicates that cardiovascular diseases account for a substantial portion, approximately 74%, of global deaths related to non-communicable diseases (NCDs) or chronic conditions.

The expansion of the cardiac valves market is expected to be fueled by the increasing healthcare expenditure. Healthcare expenditure, encompassing costs associated with healthcare goods and services, is a critical factor supporting the development and accessibility of cardiac valves. In November 2022, the Canadian Institute for Health Information reported a rise in healthcare expenditure to 0.8%, amounting to $331 billion in 2022, compared to 7.6% in 2021. This upward trend in healthcare spending is a significant driver of the growth observed in the cardiac valves market.

A notable trend in the cardiac valve market is the integration of technological advancements. Major players in the industry are focusing on innovative technologies such as neochordae implantation, annuloplasty ring, and robotic surgery to enhance their market presence. These technological advancements contribute to less invasive treatment options for heart diseases, offering patients protection against life-threatening conditions such as heart stroke and cardiac arrest. In September 2022, Edwards, a leading US-based medical technology company, introduced the Sapien 3 Ultra Resilia transcatheter heart valve featuring anti-calcification technology. This technology platform was designed to irreversibly block calcium binding sites in bioprosthetic valves.

Major companies within the cardiac valves market are actively engaged in the development of innovative products, exemplified by the introduction of next-generation transcatheter aortic valve implantation (TAVI) systems to drive market revenues. Abbott, a prominent US-based medical device company, launched the Navitor TAVI system in December 2022. This self-expanding valve is designed to treat patients with symptomatic severe native aortic stenosis deemed at high or extreme risk for open-heart surgery. The Navitor TAVI system incorporates intelligent design features, including the smart PVL-sealing NaviSeal Cuff, stable and accurate placement, exceptional single-digit gradients, and uncompromised small vessel access, catering to a broad spectrum of routine to challenging anatomies.

In January 2022, Venus Medtech, a China-based company specializing in structural heart disease treatment, completed the acquisition of Cardiovalve Ltd., an Israel-based medical device company focused on developing a transfemoral mitral valve replacement system. This strategic move enables Venus Medtech to advance clinical research in Europe and the United States while accelerating clinical development and commercialization in China. The acquisition positions Venus Medtech as China's most comprehensive platform for treating mitral and tricuspid regurgitation.

Major companies operating in the cardiac valve market include Abbott Laboratories, Colibri Heart Valve LLC, TTK HealthCare Limited, Artivion Inc., Edwards Lifesciences Corporation, Boston Scientific Corporation, Jenavalve Technology Inc., CryoLife Inc., Lepu Medical Technology Co. Ltd., Braile Biomedical, Sorin Group, Micro Interventional Devices Inc., Medtronic Inc., Lepu Medical Technology, Edward Lifesciences Corporation, Xeltis AG, Meril Life Sciences Pvt. Ltd., Auto Tissue Berlin GmbH, On-X Life Technologies Inc., Thubrikar Aortic Valve Inc., LifeNet Health Inc.

North America was the largest region in the cardiac valve market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cardiac valve market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

The countries covered in the cardiac valve market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK and USA.

The cardiac valve market consists of sales of tricuspid valves and pulmonary valves. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Cardiac Valve Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on cardiac valve market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for cardiac valve ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The cardiac valve market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Tissue Heart Valves; Transcatheter Heart Valves; Mechanical Heart Valves; Other Types
  • 2) By Position: Aortic Valve; Mitral Valve; Other Positions
  • 3) By Treatment: Cardiac Valve Repair; Cardiac Valve Replacement
  • 4) By End-Users: Hospital And Clinics; Specialty Centers; Cardiac Research Institute; Other End Users
  • Subsegments:
  • 1) By Tissue Heart Valves: Bioprosthetic Valves (e.g., porcine, bovine); Homograft Valves
  • 2) By Transcatheter Heart Valves: Transcatheter Aortic Valve Implantation (TAVI) Valves; Transcatheter Mitral Valve Repair Valves
  • 3) By Mechanical Heart Valves: Tilting Disc Valves; Bileaflet Valves; Caged Ball Valves
  • 4) By Other Types: Conduits; Stented vs. Stentless Valves
  • Companies Mentioned: Abbott Laboratories; Colibri Heart Valve LLC; TTK HealthCare Limited; Artivion Inc.; Edwards Lifesciences Corporation; Boston Scientific Corporation; Jenavalve Technology Inc.; CryoLife Inc.; Lepu Medical Technology Co. Ltd.; Braile Biomedical; Sorin Group; Micro Interventional Devices Inc.; Medtronic Inc.; Lepu Medical Technology; Edward Lifesciences Corporation; Xeltis AG; Meril Life Sciences Pvt. Ltd.; Auto Tissue Berlin GmbH; On-X Life Technologies Inc.; Thubrikar Aortic Valve Inc.; LifeNet Health Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Cardiac Valve Market Characteristics

3. Cardiac Valve Market Trends And Strategies

4. Cardiac Valve Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Cardiac Valve Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Cardiac Valve PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Cardiac Valve Market Growth Rate Analysis
  • 5.4. Global Cardiac Valve Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Cardiac Valve Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Cardiac Valve Total Addressable Market (TAM)

6. Cardiac Valve Market Segmentation

  • 6.1. Global Cardiac Valve Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Tissue Heart Valves
  • Transcatheter Heart Valves
  • Mechanical Heart Valves
  • Other Types
  • 6.2. Global Cardiac Valve Market, Segmentation By Position, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Aortic Valve
  • Mitral Valve
  • Other Positions
  • 6.3. Global Cardiac Valve Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Cardiac Valve Repair
  • Cardiac Valve Replacement
  • 6.4. Global Cardiac Valve Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospital And Clinics
  • Specialty Centers
  • Cardiac Research Institute
  • Other End Users
  • 6.5. Global Cardiac Valve Market, Sub-Segmentation Of Tissue Heart Valves, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Bioprosthetic Valves (e.g., porcine, bovine)
  • Homograft Valves
  • 6.6. Global Cardiac Valve Market, Sub-Segmentation Of Transcatheter Heart Valves, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Transcatheter Aortic Valve Implantation (TAVI) Valves
  • Transcatheter Mitral Valve Repair Valves
  • 6.7. Global Cardiac Valve Market, Sub-Segmentation Of Mechanical Heart Valves, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Tilting Disc Valves
  • Bileaflet Valves
  • Caged Ball Valves
  • 6.8. Global Cardiac Valve Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Conduits
  • Stented vs. Stentless Valves

7. Cardiac Valve Market Regional And Country Analysis

  • 7.1. Global Cardiac Valve Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Cardiac Valve Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Cardiac Valve Market

  • 8.1. Asia-Pacific Cardiac Valve Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Cardiac Valve Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Cardiac Valve Market, Segmentation By Position, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Cardiac Valve Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Cardiac Valve Market

  • 9.1. China Cardiac Valve Market Overview
  • 9.2. China Cardiac Valve Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Cardiac Valve Market, Segmentation By Position, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Cardiac Valve Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Cardiac Valve Market

  • 10.1. India Cardiac Valve Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Cardiac Valve Market, Segmentation By Position, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Cardiac Valve Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Cardiac Valve Market

  • 11.1. Japan Cardiac Valve Market Overview
  • 11.2. Japan Cardiac Valve Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Cardiac Valve Market, Segmentation By Position, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Cardiac Valve Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Cardiac Valve Market

  • 12.1. Australia Cardiac Valve Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Cardiac Valve Market, Segmentation By Position, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Cardiac Valve Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Cardiac Valve Market

  • 13.1. Indonesia Cardiac Valve Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Cardiac Valve Market, Segmentation By Position, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Cardiac Valve Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Cardiac Valve Market

  • 14.1. South Korea Cardiac Valve Market Overview
  • 14.2. South Korea Cardiac Valve Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Cardiac Valve Market, Segmentation By Position, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Cardiac Valve Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Cardiac Valve Market

  • 15.1. Western Europe Cardiac Valve Market Overview
  • 15.2. Western Europe Cardiac Valve Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Cardiac Valve Market, Segmentation By Position, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Cardiac Valve Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Cardiac Valve Market

  • 16.1. UK Cardiac Valve Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Cardiac Valve Market, Segmentation By Position, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Cardiac Valve Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Cardiac Valve Market

  • 17.1. Germany Cardiac Valve Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Cardiac Valve Market, Segmentation By Position, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Cardiac Valve Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Cardiac Valve Market

  • 18.1. France Cardiac Valve Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Cardiac Valve Market, Segmentation By Position, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Cardiac Valve Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Cardiac Valve Market

  • 19.1. Italy Cardiac Valve Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Cardiac Valve Market, Segmentation By Position, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Cardiac Valve Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Cardiac Valve Market

  • 20.1. Spain Cardiac Valve Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Cardiac Valve Market, Segmentation By Position, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Cardiac Valve Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Cardiac Valve Market

  • 21.1. Eastern Europe Cardiac Valve Market Overview
  • 21.2. Eastern Europe Cardiac Valve Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Cardiac Valve Market, Segmentation By Position, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Cardiac Valve Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Cardiac Valve Market

  • 22.1. Russia Cardiac Valve Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Cardiac Valve Market, Segmentation By Position, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Cardiac Valve Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Cardiac Valve Market

  • 23.1. North America Cardiac Valve Market Overview
  • 23.2. North America Cardiac Valve Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Cardiac Valve Market, Segmentation By Position, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Cardiac Valve Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Cardiac Valve Market

  • 24.1. USA Cardiac Valve Market Overview
  • 24.2. USA Cardiac Valve Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Cardiac Valve Market, Segmentation By Position, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Cardiac Valve Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Cardiac Valve Market

  • 25.1. Canada Cardiac Valve Market Overview
  • 25.2. Canada Cardiac Valve Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Cardiac Valve Market, Segmentation By Position, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Cardiac Valve Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Cardiac Valve Market

  • 26.1. South America Cardiac Valve Market Overview
  • 26.2. South America Cardiac Valve Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Cardiac Valve Market, Segmentation By Position, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Cardiac Valve Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Cardiac Valve Market

  • 27.1. Brazil Cardiac Valve Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Cardiac Valve Market, Segmentation By Position, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Cardiac Valve Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Cardiac Valve Market

  • 28.1. Middle East Cardiac Valve Market Overview
  • 28.2. Middle East Cardiac Valve Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Cardiac Valve Market, Segmentation By Position, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Cardiac Valve Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Cardiac Valve Market

  • 29.1. Africa Cardiac Valve Market Overview
  • 29.2. Africa Cardiac Valve Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Cardiac Valve Market, Segmentation By Position, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Cardiac Valve Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Cardiac Valve Market Competitive Landscape And Company Profiles

  • 30.1. Cardiac Valve Market Competitive Landscape
  • 30.2. Cardiac Valve Market Company Profiles
    • 30.2.1. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Colibri Heart Valve LLC Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. TTK HealthCare Limited Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Artivion Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Edwards Lifesciences Corporation Overview, Products and Services, Strategy and Financial Analysis

31. Cardiac Valve Market Other Major And Innovative Companies

  • 31.1. Boston Scientific Corporation
  • 31.2. Jenavalve Technology Inc.
  • 31.3. CryoLife Inc.
  • 31.4. Lepu Medical Technology Co. Ltd.
  • 31.5. Braile Biomedical
  • 31.6. Sorin Group
  • 31.7. Micro Interventional Devices Inc.
  • 31.8. Medtronic Inc.
  • 31.9. Lepu Medical Technology
  • 31.10. Edward Lifesciences Corporation
  • 31.11. Xeltis AG
  • 31.12. Meril Life Sciences Pvt. Ltd.
  • 31.13. Auto Tissue Berlin GmbH
  • 31.14. On-X Life Technologies Inc.
  • 31.15. Thubrikar Aortic Valve Inc.

32. Global Cardiac Valve Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Cardiac Valve Market

34. Recent Developments In The Cardiac Valve Market

35. Cardiac Valve Market High Potential Countries, Segments and Strategies

  • 35.1 Cardiac Valve Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Cardiac Valve Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Cardiac Valve Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer